Literature DB >> 29505193

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U Correll1,2, John Lauriello3.   

Abstract

Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29505193     DOI: 10.4088/JCP.AL17017WC1C

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

Review 1.  Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019.

Authors:  Luisa Peters; Amanda Krogmann; Laura von Hardenberg; Katja Bödeker; Viktor B Nöhles; Christoph U Correll
Journal:  Curr Psychiatry Rep       Date:  2019-11-19       Impact factor: 5.285

2.  Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN).

Authors:  Petru Ifteni; Paula-Simina Petric; Andreea Teodorescu
Journal:  Front Psychiatry       Date:  2021-12-07       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.